1 Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer Journal of Clinical Oncology, May 23, 2013
2 Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type k-ras colorectal carcinoma Journal of Clinical Oncology, May 23, 2013
3 Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer Clinical Cancer Research, May 24, 2013
4 Egg consumption in relation to risk of cardiovascular disease and diabetes: a systematic review and meta-analysis American Journal of Clinical Nutrition, May 21, 2013 Evidence Based Medicine Review Article
5 Roux-en-y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: The diabetes surgery study randomized clinical trial JAMA, June 5, 2013 Evidence Based Medicine
6 Systolic Blood Pressure and Cardiovascular Outcomes During Treatment of Hypertension American Journal of Medicine, May 24, 2013 Evidence Based Medicine
7 The ubiquitin-CXCR4 axis plays an important role in acute lung-infection-enhanced lung tumor metastasis Clinical Cancer Research, May 23, 2013
8 Benefit of Immediate Beta-Blocker Therapy on Mortality in Patients With ST-Segment Elevation Myocardial Infarction Critical Care Medicine, May 20, 2013
9 Comparative effectiveness of a complex Ayurvedic treatment and conventional standard care in osteoarthritis of the knee -- study protocol for a randomized controlled trial Trials, June 4, 2013 Evidence Based Medicine
10 Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the reduce randomized clinical trial JAMA, May 24, 2013 Evidence Based Medicine
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor